Cns Pharmaceuticals Inc [NASDAQ: CNSP] jumped around 0.03 points on Tuesday, while shares priced at $0.17 at the close of the session, up 17.95%.
Compared to the average trading volume of 4.94M shares, CNSP reached a trading volume of 10896761 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Cns Pharmaceuticals Inc [CNSP]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CNSP shares is $1500.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CNSP stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Cns Pharmaceuticals Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on December 28, 2020. While these analysts kept the previous recommendation, Ladenburg Thalmann raised their target price to Buy. The new note on the price target was released on August 24, 2020, representing the official price target for Cns Pharmaceuticals Inc stock.
How has CNSP stock performed recently?
Cns Pharmaceuticals Inc [CNSP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.86. With this latest performance, CNSP shares dropped by -83.94% in over the last four-week period, additionally sinking by -98.83% over the last 6 months – not to mention a drop of -99.81% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CNSP stock in for the last two-week period is set at 22.09, with the RSI for the last a single of trading hit 22.54, and the three-weeks RSI is set at 24.30 for Cns Pharmaceuticals Inc [CNSP]. The present Moving Average for the last 50 days of trading for this stock 1.2510, while it was recorded at 0.1453 for the last single week of trading, and 28.4549 for the last 200 days.
Cns Pharmaceuticals Inc [CNSP]: Deeper insight into the fundamentals
Cns Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.31 and a Current Ratio set at 0.31.
Earnings analysis for Cns Pharmaceuticals Inc [CNSP]
With the latest financial reports released by the company, Cns Pharmaceuticals Inc posted -2.1/share EPS, while the average EPS was predicted by analysts to be reported at -3.3/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 1.2. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CNSP.
Insider trade positions for Cns Pharmaceuticals Inc [CNSP]
There are presently around $0.56%, or 0.57%% of CNSP stock, in the hands of institutional investors.
